Back to Results
First PageMeta Content
Cell lines / Prostate-specific membrane antigen / PC3 / Prostate cancer / Lymphocyte / LNCaP / T cell / Glutamate carboxypeptidase II / Medicine / Biology / Cancer research


Phase Ia/Ib Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer after Nonmyeloablative Conditioning Richard P Junghans, PhD, MD Director, Biotherapeutics Development Lab
Add to Reading List

Document Date: 2013-12-16 10:09:20

Open Document

File Size: 919,18 KB

Share Result on Facebook

Country

United States / /

Event

Judicial Event / /

Facility

University School / /

MedicalCondition

hormone refractory disease / Tumor / prostate tumors / Advanced Prostate Cancer / /

Organization

Boston University School of Medicine / Biotherapeutics Development Lab / /

Person

Richard P Junghans / /

Position

Cytotoxicity %TUMOR CELL KILLING ANTI-PSMA DESIGNER / Anti-PSMA Designer / Designer / Director / Professor of Surgery / Chief / Division of Surgical Research Roger Williams / /

SocialTag